People · Operator
Named in public records as an officer, director or promoter · active 2016–2024 · Pharma, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Inflammasome Therapeutics, Inc. | — | Pharma | Seed | $6.2M | $9.4M | 2023 |
| iVeena Delivery Systems, Inc. | — | Pharmaceuticals | Seed | $5.6M | $81.0M | 2016 |
Balamurali Ambati at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Balamurali Ambati on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jayakrishna Ambati | 2 | 2 |
| James Jensen | 1 | 7 |
| David Robinson | 1 | 6 |
| Barry Hanover | 1 | 3 |
| Ned Weinshenker | 1 | 2 |
| Paul Ashton | 1 | 1 |
| Napoleone Ferrara | 1 | 1 |
| Mary Weber | 1 | 1 |
| Joon Lee | 1 | 1 |
| Jayakrishna U Ambati | 1 | 1 |
| Barry U Hanover | 1 | 1 |
| Ned U Weinshenker | 1 | 1 |
| Heffernan U Ron | 1 | 1 |
| Robert U Dempsey | 1 | 1 |
| Gerald Simmons | 1 | 1 |
| Balamurali U Ambati | 1 | 1 |
| James U Jensen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.